Pathology
Pathology
批准号:
10491163
负责人:
RUBEN D CARRASCO
金额:
$11.42万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
未结题
起止时间:
2016-09-01 至 2026-08-31
关键词:
AddressArchivesAreaAutomobile DrivingB-Cell Antigen ReceptorBiologic CharacteristicBiologicalBiologyBiopsyCell LineCellsChemotherapy-Oncologic ProcedureChronic Lymphocytic LeukemiaClinicalClinical TrialsComplicationDataDevelopmentDiagnosisDiagnosticDiseaseDisease modelDissectionDoctor of PhilosophyDocumentationDrug resistanceEngineeringEngraftmentEnrollmentEvaluationFibrous capsule of kidneyFormalinFoundationsFreezingFutureGeneticGenetic PolymorphismGenomeGenomicsGoalsGrantHematologic NeoplasmsHematopathologyHematopoietic stem cellsHistologicHistopathologyHumanHuman ResourcesImmunocompromised HostImmunodeficient MouseImmunohistochemistryImplantIn VitroInfrastructureInjectionsInstitutionInvestigationLesionLymphomaMS4A1 geneMalignant NeoplasmsMissionModelingMolecularMorphologyMusOperative Surgical ProceduresPTPRC geneParaffin EmbeddingPathogenesisPathologicPathologyPathway interactionsPatient-Focused OutcomesPatientsPhenotypePreparationProceduresProcessProteomicsReceptor GeneRefractoryReportingResearchResearch PersonnelResearch SupportResourcesRestRichter&aposs SyndromeRiskSamplingSignal TransductionSiteSlideSmall-Cell LymphomaSolidSpecimenStereotypingStudy SectionTailTestingTissue MicroarrayTissuesTranslationsTransplantationTumor BankValidationVariantVeinsbasecandidate validationcell bankchromosome 13q lossdel(17p13)designeffective therapyexperimental studygenome editingimplantationimprovedin vivoin vivo Modelinnovationinterestlarge cell Diffuse non-Hodgkin&aposs lymphomalymphoid neoplasmmouse modelnovelnovel markerpatient derived xenograft modelphenomepre-clinicalprogramsprospectivesample archivesubcutaneoustherapeutic targettissue resourcetooltranscriptomicstreatment responsetumortumor microenvironment
中文摘要
项目摘要
病理学核心(2)将提供无缝的翻译基础设施,以支持RS组织的研究
计划在这个应用程序中。这将包括体外扩增原代RS样本,
免疫受损小鼠,以努力产生体内RS primagraft模型,用于提供新鲜或冷冻的
用于体外分子和体内功能实验的RS细胞。RS样本将具有完整的临床注释
以及分子表征(来自项目1/核心3),并将从患者样本中获得
通过DFCI RS生物样本核心(1)存储的样本以及来自DFCI和合作机构的新入组患者
机构职能体系这些模型是一个重要的和日益受到赞赏的工具,用于分析新发现的
遗传病变,相关信号传导和生存途径,合理的治疗靶点和机制,
耐药性RS细胞将通过尾静脉注射或直接植入皮下或下方递送。
肾包膜然后,这些primagraft模型可以用于表征生物学和评估对
RS细胞的治疗。该病理学核心还将:(i)提供RS患者的FFPE存档样本,(ii)
提供用于后续研究的人类RS样品的组织病理学分析,(iii)产生组织
微阵列(和CLL/RS对的载玻片用于功能验证,(iv)提供形态学和组织病理学
在工程小鼠中分析小鼠RS样品,和(v)产生组织阵列和载玻片以研究
组织病理学和进行小鼠RS工程小鼠免疫组织化学表征。
英文摘要
Project Summary
This Pathology Core (2) will provide a seamless translational infrastructure to support the research on RS tissues
planned in this application. This will include the ex vivo expansion of primary RS samples in
immunocompromised mice in an effort to generate in vivo RS primagraft models for provision of fresh or frozen
RS cells for in vitro molecular and in vivo functional experiments. The RS samples will have full clinical annotation
as well as molecular characterization (from Project 1/Core 3), and will be derived from patient samples already
stored through the DFCI RS Biospecimen Core (1) as well as newly enrolled patients from DFCI and collaborating
institutions. These models are a significant and increasingly appreciated tool for the analysis of newly identified
genetic lesions, associated signaling and survival pathways, rational therapeutic targets and mechanisms of
drug resistance. RS cells will be delivered by tail vein injection or directly implanted subcutaneously or beneath
the renal capsule. These primagraft models could then be used to characterize biology and assess response to
therapy of the RS cells. This Pathology Core will also: (i) provide FFPE archived samples from RS patients, (ii)
provide histo-pathological analysis of human RS samples to be used in subsequent studies, (iii) generate tissue
microarrays (and slides of CLL/RS pairs for functional validation, (iv) provide morphologic and histopathologic
analysis of mouse RS samples in engineered mice, and (v) generate tissue arrays and slides to study
histopathology and perform immunohistochemical characterization of mouse RS engineered mice.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigating and modeling MYD88L265P and co-occurring mutations in mature B-cell malignancies
-
批准号:10501718
-
项目类别:
-
资助金额:$43.37万
-
财政年份:2022
-
负责人:RUBEN D CARRASCO
-
依托单位:
Investigating and modeling MYD88L265P and co-occurring mutations in mature B-cell malignancies
-
批准号:10670435
-
项目类别:
-
资助金额:$43.68万
-
财政年份:2022
-
负责人:RUBEN D CARRASCO
-
依托单位:
Development of microRNA (miR)-based cell-targeted polymeric nanoparticles for myeloma therapy
-
批准号:10607998
-
项目类别:
-
资助金额:$53.99万
-
财政年份:2021
-
负责人:RUBEN D CARRASCO
-
依托单位:
Development of microRNA (miR)-based cell-targeted polymeric nanoparticles for myeloma therapy
-
批准号:10348217
-
项目类别:
-
资助金额:$53.99万
-
财政年份:2021
-
负责人:RUBEN D CARRASCO
-
依托单位:
Development of microRNA (miR)-based cell-targeted polymeric nanoparticles for myeloma therapy
-
批准号:10206506
-
项目类别:
-
资助金额:$56.94万
-
财政年份:2021
-
负责人:RUBEN D CARRASCO
-
依托单位:
Pathology
-
批准号:10270042
-
项目类别:
-
资助金额:$11.95万
-
财政年份:2016
-
负责人:RUBEN D CARRASCO
-
依托单位:
Validating the eCyPA/CD147 signaling complex for myeloma therapy
-
批准号:9298395
-
项目类别:
-
资助金额:$39.48万
-
财政年份:2015
-
负责人:RUBEN D CARRASCO
-
依托单位:
Validating the eCyPA/CD147 signaling complex for myeloma therapy
-
批准号:9103033
-
项目类别:
-
资助金额:$39.48万
-
财政年份:2015
-
负责人:RUBEN D CARRASCO
-
依托单位:
Validating the eCyPA/CD147 signaling complex for myeloma therapy
-
批准号:8940603
-
项目类别:
-
资助金额:$39.37万
-
财政年份:2015
-
负责人:RUBEN D CARRASCO
-
依托单位:
Validating the eCyPA/CD147 signaling complex for myeloma therapy
-
批准号:9512894
-
项目类别:
-
资助金额:$39.48万
-
财政年份:2015
-
负责人:RUBEN D CARRASCO
-
依托单位:
Mining B-catenin/BCL9 transcriptional complex for Multiple Myeloma therapeutics
-
批准号:8090385
-
项目类别:
-
资助金额:$34.62万
-
财政年份:2010
-
负责人:RUBEN D CARRASCO
-
依托单位:
Mining B-catenin/BCL9 transcriptional complex for Multiple Myeloma therapeutics
-
批准号:8676712
-
项目类别:
-
资助金额:$33.58万
-
财政年份:2010
-
负责人:RUBEN D CARRASCO
-
依托单位:
Mining B-catenin/BCL9 transcriptional complex for Multiple Myeloma therapeutics
-
批准号:8463474
-
项目类别:
-
资助金额:$32.54万
-
财政年份:2010
-
负责人:RUBEN D CARRASCO
-
依托单位:
Mining B-catenin/BCL9 transcriptional complex for Multiple Myeloma therapeutics
-
批准号:8260868
-
项目类别:
-
资助金额:$34.62万
-
财政年份:2010
-
负责人:RUBEN D CARRASCO
-
依托单位:
Novel System to Study Telomere Dynamics in Hemotopoiesis
-
批准号:6915510
-
项目类别:
-
资助金额:$12.47万
-
财政年份:2001
-
负责人:RUBEN D CARRASCO
-
依托单位:
Novel System to Study Telomere Dynamics in Hemotopoiesis
-
批准号:6782525
-
项目类别:
-
资助金额:$12.47万
-
财政年份:2001
-
负责人:RUBEN D CARRASCO
-
依托单位:
Novel System to Study Telomere Dynamics in Hemotopoiesis
-
批准号:6509463
-
项目类别:
-
资助金额:$12.47万
-
财政年份:2001
-
负责人:RUBEN D CARRASCO
-
依托单位:
Novel System to Study Telomere Dynamics in Hemotopoiesis
-
批准号:6360405
-
项目类别:
-
资助金额:$12.45万
-
财政年份:2001
-
负责人:RUBEN D CARRASCO
-
依托单位:
Novel System to Study Telomere Dynamics in Hemotopoiesis
-
批准号:6604100
-
项目类别:
-
资助金额:$12.47万
-
财政年份:2001
-
负责人:RUBEN D CARRASCO
-
依托单位:
海外基金